Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Adcetris
Adcetris
ASCO spotlight: Antibody-drug conjugates arrive
Fierce Biotech
Fri, 06/1/12 - 12:28 pm
ASCO
antibody-drug conjugate
Roche
Genentech
Immunogen
T-DM1
Adcetris
Seattle Genetics
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
It's Fashionably Late, but This Biotech's Party Is Just Starting
Motley Fool
Sat, 04/14/12 - 12:27 pm
Seattle Genetics
Adcetris
Hodgkin's lymphoma
anaplastic large-cell lymphoma
Seattle Genetics: A Cancer Niche Too Small
TheStreet.com
Mon, 03/5/12 - 11:11 am
Seattle Genetics
Adcetris
systemic anaplastic large cell lymphoma
Hodgkin's lymphoma
Seattle Genetics: Boxed Warning Is A Non-Event
Seeking Alpha
Sun, 01/22/12 - 12:32 pm
Seattle Genetics
progressive multifocal leukoencephalopathy
PML
Adcetris
Hodgkin's lymphoma
anaplastic large-cell lymphoma
Warning: Don't Sell on This News (Seattle Genetics)
Motley Fool
Sun, 01/15/12 - 01:36 pm
Seattle Genetics
progressive multifocal leukoencephalopathy
PML
Adcetris
Seattle Genetics Lymphoma Drug Gets Boxed Warning on Brain Infection Risk
Bloomberg
Sat, 01/14/12 - 11:25 am
Seattle Genetics
Adcetris
Hodgkin's lymphoma
progressive multifocal leukoencephalopathy
PML
What to Look For With Seattle Genetics in 2012
Motley Fool
Thu, 12/29/11 - 10:34 pm
Seattle Genetics
Adcetris
Seattle Genetics’ Adcetris Is Well Tolerated in Drug Combination
Bloomberg
Tue, 12/13/11 - 11:48 am
Adcetris
Seattle Genetics
Hodgkin's lymphoma
Seattle Genetics Gains After Analyst Raises Sales Estimate for Cancer Drug
Bloomberg
Mon, 11/28/11 - 04:48 pm
Seattle Genetics
Hodgkin's lymphoma
Adcetris
Analyst: Seattle Genetics should outperform forecasts
bizjournals
Sat, 10/22/11 - 12:13 pm
Seattle Genetics
Adcetris
Hodgkin's lymphoma
anaplastic large-cell lymphoma
Millennium and Seattle Genetics Present Clinical Data on ADCETRIS™ (Brentuximab Vedotin) in Pediatric Patients at EMCC Annual Meeting
Yahoo/BusinessWire
Sat, 09/24/11 - 12:48 pm
Seattle Genetics
Millennium
Adcetris
Hodgkin's lymphoma
anaplastic large-cell lymphoma
Seattle Genetics Faces Hurdles as Investors Dread Dendreon-Like Rollout
Bloomberg
Mon, 08/22/11 - 06:13 pm
Seattle Genetics
Dendreon
Provenge
Adcetris
lymphoma
Ahead of the Bell: Seattle Genetics shares jump
Yahoo/AP
Mon, 08/22/11 - 11:49 am
Seattle Genetics
FDA
Adcetris
anaplastic large-cell lymphoma
Seattle Genetics Announces FDA Accelerated Approval of ADCETRIS™ (Brentuximab Vedotin) for Two Indications
Yahoo/BusinessWire
Sat, 08/20/11 - 09:57 pm
systemic anaplastic large cell lymphoma
lymphoma
Hodgkin's lymphoma
Adcetris
Biotech Calendar: 2011-12 FDA Drug Approvals
TheStreet.com
Thu, 08/11/11 - 12:37 pm
biotech
drug approvals
FDA
Eyelea
Regeneron
Dendreon
Provenge
NuPathe
Zelrix
Adcetris
Seattle Genetics
Soliris
Alexion
Dapagliflozin
AstraZeneca
Bristol-Myers Squibb
EXPAREL
Pacira
Roche
Zelboraf
Iluvien
Alimera
Bio-T-Gel
Teva Pharmaceuticals
BioSante
Zevalin
Spectrum
ruxolitinib
Incyte
Novartis
Pfizer
crizotinib
Antares
Anturol
Bydureon
Amlyin
Eli Lilly
Alkermes
AZ-004
Alexza
Corlux
Corcept Therapeutics
Affymax
Takeda
peginesatide
Levadex
MAP Pharmaceuticals
Biotech Calendar: Key Dates for August
TheStreet.com
Tue, 08/2/11 - 12:29 pm
Alexa
Gilead Sciences
Regeneron
Dendreon
NuPathe
Provenge
Adcetris
Seattle Genetics
Eyelea
Btripla
Zelrix
AZ-004
Seattle Genetics: Adcetris Panel Reconvenes (live blog)
TheStreet.com
Thu, 07/14/11 - 01:28 pm
Seattle Genetics
advisory panels
Adcetris
FDA
anaplastic large-cell lymphoma
Millennium and Seattle Genetics Present Clinical Data on ADCETRIS (Brentuximab Vedotin) in Systemic ALCL at EHA Annual Meeting
Enhanced Online News
Sat, 06/11/11 - 10:58 am
systemic anaplastic large cell lymphoma
Seattle Genetics
Millennium
Adcetris
Pages
« first
‹ previous
1
2
3
4